Veozah (fezolinetant) is a neurokinin 3 (NK3) receptor antagonist used for the treatment of moderate to severe vasomotor symptoms (VMS) due to menopause. Vasomotor symptoms (VMS) are the feelings of warmth in the chest, face, and neck, or sudden intense feelings of heat and sweating (hot flushes or hot flashes).
Recommended Dosage: The recommended dosage is a single Veozah tablet of 45 mg orally once daily with or without food. Take tablets together with liquids and swallow whole. Do not chew, cut, or crush tablets. Administer this medicine orally at about the same time each day.
If a dose is missed or not taken at the scheduled time, administer the missed dose as quickly as possible, unless there is less than 12 hours before the very next scheduled dose. Return to the standard schedule the following day.